BUZZ-Australia's Cyclopharm rises on agreement with Northwestern Medicine

** Shares of Australia's Cyclopharm CYC.AX rise as much as 12% to A$0.84, their biggest intraday pct gain since February 18

** Stock at its highest level since February 27

** Radiopharmaceuticals maker secures multi-site agreement with Northwestern Memorial Healthcare, an academic health system based in Chicago, U.S.

** Agreement provides for one immediate co's Technegas installation at the Northwestern Memorial Hospital in Chicago

** Stock has fallen 14.3% this year, including the session's moves


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.